Indications, methodology, and classification of results of tilt-table testing11This article may contain discussion of off-label or investigational uses (not yet approved by the FDA) of various therapeutic agents. Please refer to the box provided on page 2Q of this supplement for a disclosure of such agents.
Authors:
- Daniel M BloomfieldDBDaniel M Bloomfield
- 1 October 1999
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (8) , 10-19
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The normal response to prolonged passive head up tilt testingHeart, 2000
- Panel consensusThe American Journal of Cardiology, 1999
- The Economics of Treating Vasovagal SyncopePacing and Clinical Electrophysiology, 1997
- Neurally Mediated Syncopal Syndromes: Pathophysiological Concepts and Clinical EvaluationPacing and Clinical Electrophysiology, 1997
- Changes in Plasma Epinephrine Concentration and in Heart Rate During Head‐Up Tilt Testing in Patients with Neurocardiogenic Syncope:Journal of Cardiovascular Electrophysiology, 1996
- Tilt table testing for assessing syncopeJACC, 1996
- Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncopeThe American Journal of Cardiology, 1995
- Tilt Table Testing for Evaluation of Neurally‐Mediated (Cardioneurogenic) Syncope: Rationale and Proposed ProtocolsPacing and Clinical Electrophysiology, 1991
- Provocation of Bradycardia and Hypotension by Isoproterenol and Upright Posture in Patients with Unexplained SyncopeNew England Journal of Medicine, 1989
- HEAD-UP TILT: A USEFUL TEST FOR INVESTIGATING UNEXPLAINED SYNCOPEThe Lancet, 1986